<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343086">
  <stage>Registered</stage>
  <submitdate>22/06/2011</submitdate>
  <approvaldate>23/06/2011</approvaldate>
  <actrnumber>ACTRN12611000639921</actrnumber>
  <trial_identification>
    <studytitle>Comparison between two clomiphene citrate protocols for induction of ovulation in clomiphene resistant Polycystic ovarian disease.</studytitle>
    <scientifictitle>Comparison between two clomiphene citrate protocols for induction of ovulation in clomiphene resistant Polycystic ovarian disease.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Polycystic ovarian disease.</healthcondition>
    <healthcondition>Resistant Anovulation</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Fertility including in vitro fertilisation</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>clomiphene citrate oral tablets 100 mg daily for 10 days, starting within 5 days of induced menses.</interventions>
    <comparator>control group clomiphene citrate oral tablets 200 mg daily for 5 days, starting within 5 days of induced menses.</comparator>
    <control>Dose comparison</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>ovulation detected by transvaginal follicle scanning, and serum progesterone value.</outcome>
      <timepoint>after the end of treatment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>chemical pregnancy by serum HCG assay.</outcome>
      <timepoint>after the end of cycle</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>clinical pregnancy by ultrasonography.</outcome>
      <timepoint>2 weeks after serum pregnancy test.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>married, nulligravida, polycystic ovarian disease, resistant to clomiphene citrate drug in previous cycle/s</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>35</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>previous pelvic surgery, other causes of infertility, BMI&gt;35</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Evaluation of eligibility, informed consent.</concealment>
    <sequence>Randomization using computer generated tables, results kept in sealed envelopes till the time of starting treatment.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/01/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Mervat Sheikh Elarab Elsedeek Omran</primarysponsorname>
    <primarysponsoraddress>649 Elhorreya street, Janaclis, Elraml District, Alexandria Egypt.
post code 03312</primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry>Egypt</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of the study is to test if either doubling the dose of clomiphene citrate or doubling the duration would make previously unresponsive patients respond and ovulate, and to compare the efficacy of either approach.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The ethics committee of Alexandria faculty of medicine, Alexandria university.</ethicname>
      <ethicaddress>Alexandria faculty of Medicine, Elraml district, Alexandria, Egypt. post code 03312</ethicaddress>
      <ethicapprovaldate>29/05/2008</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Egypt</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Mervat Sheikh elarab Elsedeek</name>
      <address>649 Elhorreya street, Janaclis, Elraml District, Alexandria Egypt.
post code 03312</address>
      <phone>+203 5759915</phone>
      <fax />
      <email>mervatsheikhelarab@yahoo.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mervat Sheikh elarab Elsedeek</name>
      <address>649 Elhorreya street, Janaclis, Elraml District, Alexandria Egypt.
post code 03312</address>
      <phone>+203 5759915</phone>
      <fax />
      <email>mervatsheikhelarab@yahoo.com</email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mervat Sheikh elarab Elsedeek</name>
      <address>649 Elhorreya street, Janaclis, Elraml District, Alexandria Egypt.
post code 03312</address>
      <phone>+203 5759915</phone>
      <fax />
      <email>mervatsheikhelarab@yahoo.com</email>
      <country>Egypt</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>